Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04092179
Title Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University Health Network, Toronto

myelodysplastic syndrome

acute myeloid leukemia

myeloproliferative neoplasm


Enasidenib + Venetoclax

Age Groups: adult | senior
Covered Countries CAN

Additional content available in CKB BOOST